Hwang Lab

Hwang Lab


Raised: $613

Goal: $2,000

Welcome to our team fundraising page!

Welcome to The Hwang Lab’s PanCAN PurpleStride Team Fundraising Page!

Dr. William Hwang's lab is walking at PanCAN PurpleStride on April 27, 2024, to fundraise for pancreatic cancer research and patient support. The Hwang lab leverages innovative technologies and methodologies to understand the mechanisms driving pancreatic cancer and therapeutic resistance with the ultimate goal of discovering novel and effective therapeutics. Although his lab at MGH recently opened, Dr. Hwang’s leadership and determination stimulates a dynamic research environment that promises new discoveries in the near and distant future.

The field of pancreatic cancer research has been historically understudied and underfunded. Despite recent progress, treatment options remain limited, and long-term survival rates remain low. Studies estimate that pancreatic cancer will become the second leading cause of cancer-related deaths by 2030. To help impact the lives of pancreatic cancer patients, we need your help in supporting new and ongoing research.

The importance of funding cannot be understated: it directly impacts the quantity and quality of research that ultimately benefits pancreatic cancer patients, their families, and society at large. The more funds raised, the greater the impact.  Donations of any size are valued.

The Hwang Lab extends its appreciation, gratitude, and thanks for your vital support! 

“No research without action, no action without research” - Kurt Lewin

Loading ...
Donor Name
Amount Donated

About PanCAN PurpleStride

Local action. Nationwide impact. This is PanCAN PurpleStride, the ultimate walk to end pancreatic cancer.

On Saturday, April 27, 2024, at nearly 60 events across the country, pancreatic cancer survivors, families, caregivers, researchers and supporters will join together and walk to honor everyone affected by the disease.

PurpleStride is PanCAN's signature community celebration, raising money to fight pancreatic cancer on all fronts — through research, clinical initiatives, patient services, advocacy and nationwide volunteer support. Learn more.